5. References

  1.  
  2. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2022. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed November 21, 2022.
  3. IMB Micromedex® DRUGDEX® (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu. Accessed November 21, 2022.
  4. Almotriptan (Axert®) package insert. Ajanta Pharma Limited, November 2021. 
  5. Eletriptan (Relpax®) package insert. Ajanta Pharma Limited, November 2021.
  6. Frovatriptan (Frova®) package insert. Ingenus Pharmaceuticals, May 2022.
  7. Naratriptan (Amerge®) package insert. GlaxoSmithKline, October 2020.
  8. Rizatriptan (Maxalt® and Maxalt-MLT®) package insert. Breckenridge Pharmaceutical, Inc. August 2022.
  9. Sumatriptan tablets (Imitrex®) package insert. GlaxoSmithKline, December 2020.
  10. Sumatriptan injection (Imitrex®) package insert. GlaxoSmithKline, December 2021.
  11. Sumatriptan nasal spray (Imitrex®) package insert. Lannett Company, January 2022.
  12. Sumatriptan nasal powder (Onzetra® Xsail®) package insert. Currax Pharmaceuticals, February 2021.
  13. Sumatriptan nasal spray (Tosymra®) package insert. Upsher-Smith Laboratories, February 2021.
  14. Sumatriptan succinate injection (Zembrace® SymTouch®) package insert. Upsher-Smith Laboratories, February 2021.
  15. Zolmitriptan tablets (Zomig®) package insert. Ajanta Pharma, November 2021.
  16. Zolmitriptan orally disintegrating tablets (Zomig-ZMT®) package insert. Glenmark Pharmaceuticals, September 2022.
  17. Zolmitriptan nasal spray (Zomig®) package insert. Padagis Israel Pharmaceuticals, October 2021.
  18. Sumatriptan/naproxen tablets (Treximet®) Package Insert. Aurobindo Pharma, May 2021.
  19. Winner P, Linder SL, Lipton RB, et al. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.  Headache. 2007;47(4):511-8.
  20. Ahonen K, Hamalainen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology. 2004;62:883-7.
  21. Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 2000;106:989-97.
  22. Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 1999;52:507-10.
  23. Hamalainen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults? Neurology. 1997;48(4):1100-3.
  24. Evers S, Rahmann A, Kraemer C, et al. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology. 2006;67:497-9.
  25. Rothner AD, Wasiewski W, Winner P, et al. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Headache. 2006;46:101-9.
  26. Winner P, Rothner AD, Wooten JD, et al. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache. 2006;46:212-22.
  27. Linder SL. Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practice. Headache. 1996;36(7):419-422. doi:10.1046/j.1526-4610.1996.3607419.x
  28. MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache. 1994;34(10):581-582. doi:10.1111/j.1526-4610.1994.hed3410581.